Charcot-Marie-Tooth Type 1A Neuropathy
2
0
0
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
1 treatments under study, led by Exploratory Physiopathology Study Including Noninvasive Functional Explorations Carried Out In Patients With Charcotmarietooth Disease Type 1a
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 2 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (2)
Fall Risk Assessment in a Population of Charcot-Marie-Tooth Disease Type 1A (CMT 1A) by Timed Up and Go Test
Correlation Between Clinical and Electrophysiological Phenotypes in a Population of Patients With Neuropathy Charcot-Marie-Tooth Disease Type 1A
Research Network
Common Treatments
- Exploratory Physiopathology Study Including Noninvasive Functional Explorations Carried Out In Patients With Charcotmarietooth Disease Type 1a1
Active Sponsors
- University Hospital, Clermont-Ferrand2
Top Investigators
University Hospital, Clermont-Ferrand